911
Views
1
CrossRef citations to date
0
Altmetric
Editorial

One size fits all? Antibody avidity measurement against multiple antigens in maternal vaccination studies

, &
Pages 1066-1068 | Received 12 Apr 2017, Accepted 14 Apr 2017, Published online: 16 May 2017

References

  • Huygen K, Caboré RN, Maertens K, Van Damme P, Leuridan E. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Vaccine 2015; 33:4117–23; PMID:26187257; https://doi.org/10.1016/j.vaccine.2015.06.108
  • Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and wales, 2012–2013. Clin Infect Dis 2015; 60:333–7; https://doi.org/10.1093/cid/ciu821
  • Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384:1521–8; PMID:25037990; https://doi.org/10.1016/S0140-6736(14)60686-3
  • Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204:334. e1-5; https://doi.org/10.1016/j.ajog.2010.11.024
  • Vilajeliu A, Goncé A, López M, Costa J, Rocamora L, Ríos J, Teixidó I, Bayas JM; PERTU Working Group. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine 2015; 33:1056–62; PMID:25573035; https://doi.org/10.1016/j.vaccine.2014.12.062
  • Njie-Jobe J, Nyamweya S, Miles DJ, van der Sande M, Zaman S, Touray E, Hossin S, Adetifa J, Palmero M, Burl S, et al. Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years. Vaccine 2012; 30:2543–50; PMID:22314136; https://doi.org/10.1016/j.vaccine.2012.01.083
  • Letson GW, Shapiro CN, Kuehn D, Gardea C, Welty TK, Krause DS, Lambert SB, Margolis HS. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr 2004; 144:327–32; https://doi.org/10.1016/j.jpeds.2003.11.030
  • Halasa NB, Gerber MA, Chen Q, Wright PF, Edwards KM. Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants. J Infect Dis 2008; 197:1448–54; https://doi.org/10.1086/587643
  • Caboré RN, Maertens K, Dobly A, Leuridan E, Van Damme P, Huygen K. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium. Virulence 2017; Advance online publication. https://doi.org/10.1080/21505594.2017.1296998
  • Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study. Vaccine 2016; 34:142–50; PMID:26592142; https://doi.org/10.1016/j.vaccine.2015.10.100
  • Maertens K, Caboré RN, Huygen K, Vermeiren S, Hens N, Van Damme P, Leuridan E. Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. Vaccine 2016; 34:3613–9; PMID:27142328; https://doi.org/10.1016/j.vaccine.2016.04.066
  • Almanzar G, Ottensmeier B, Liese J, Prelog M. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate. J Immunol Methods 2013; 387:36–42; https://doi.org/10.1016/j.jim.2012.09.008
  • Ibrahim NM, El-kady EM, Eissa SA, Wahby AF. Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1–18 years. J Adv Res 2016; 7:105–11; PMID:26843976; https://doi.org/10.1016/j.jare.2015.03.002
  • Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content. Vaccine 2009; 27:6530–6; PMID:19729085; https://doi.org/10.1016/j.vaccine.2009.08.052
  • Abu Raya B, Bamberger E, Almog M, Peri R, Srugo I, Kessel A. Immunization of pregnant women against pertussis: The effect of timing on antibody avidity. Vaccine 2015; 33:1948–52; PMID:25744227; https://doi.org/10.1016/j.vaccine.2015.02.059
  • Prelog M, Almanzar G, Rieber N, Ottensmeier B, Zlamy M, Liese J. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine 2013; 31:387–93; PMID:23142306; https://doi.org/10.1016/j.vaccine.2012.10.105
  • Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Vaccine 2012; 30:6897–902; PMID:22981763; https://doi.org/10.1016/j.vaccine.2012.09.003
  • Englund JA, Anderson EL, Reed GF, Decker MD, Edwards KM, Pichichero ME, Steinhoff MC, Rennels MB, Deforest A, Meade BD. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96:580–4; PMID:7659480
  • Jones C, Pollock L, Barnett SM, Battersby A, Kampmann B. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine 2014; 32:996–1002; PMID:24342250; https://doi.org/10.1016/j.vaccine.2013.11.104
  • Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis 2015; 61:1637–44; https://doi.org/10.1093/cid/civ695
  • Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16:1901–6; PMID:9796041; https://doi.org/10.1016/S0264-410X(98)00226-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.